[Prospective study of thromboses of the subclavian vein after setting implantable venous access systems in cervico-facial cancerology].
Seventy-eight consecutive patients treated by chemotherapy for ENT cancers and having a subclavian catheter for venous access were studied prospectively to assess the prevalence of venous thrombosis. Thrombosis of the subclavian vein was demonstrated clinically in 4 patients and by ultrasonography in 7 patients. The prevalence of thrombosis was 14.1%. No clinical or biological predisposition factor could be identified. Subclavian thrombosis mostly occurred during the second month after implantation (91% of cases). Ultrasonography seems the most useful non-invasive technique for the diagnosis of subclavian thrombosis.
Bonfils
P
P
Service d'ORL et de Chirurgie Cervico-Faciale, Faculté Necker-Enfants Malades, Université René Descartes, Hôpital Boucicaut, Paris.
Luciani
J A
JA
Potard
G
G
Bassot
V
V
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D006801:Humans; D010039:Otorhinolaryngologic Neoplasms / Q000188:drug therapy*; D011446:Prospective Studies; D013350:Subclavian Vein; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology*; D013997:Time Factors